Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genequest is a Japanese consumer genomics and digital health company that provides direct-to-consumer genetic testing services based primarily on saliva samples. The company markets commercial testing kits including Genequest ALL and Genequest LITE, which report genetic tendencies related to health risks, physical traits, and in some offerings maternal ancestry. In addition to consumer testing, Genequest offers contract genetic analysis, joint research, genome consulting, and related services for corporations and researchers. The company emphasizes preventive health, responsible handling of genetic information, and evidence-based interpretation supported by published literature and internal research activities. Genequest was founded in 2013 and later became a wholly owned subsidiary of Sophia Holdings, while continuing to operate under the Genequest brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genequest.